Intraoperative Cardiac Arrest During Adult Liver Transplantation: Incidence and Risk Factor Analysis From 7 Academic Centers in the United States.


Journal

Anesthesia and analgesia
ISSN: 1526-7598
Titre abrégé: Anesth Analg
Pays: United States
ID NLM: 1310650

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 14 3 2020
medline: 20 1 2021
entrez: 14 3 2020
Statut: ppublish

Résumé

Intraoperative cardiac arrest (ICA) has a reported frequency of 1 in 10,000 anesthetics but has a much higher estimated incidence in orthotopic liver transplantation (OLT). Single-center studies of ICA in OLT are limited by small sample size that prohibits multivariable regression analysis of risks. Utilizing data from 7 academic medical centers, we performed a retrospective, observational study of 5296 adult liver transplant recipients (18-80 years old) between 2000 and 2017 to identify the rate of ICA, associated risk factors, and outcomes. ICA occurred in 196 cases (3.7% 95% confidence interval [CI], 3.2-4.2) and mortality occurred in 62 patients (1.2%). The intraoperative mortality rate was 31.6% in patients who experienced ICA. In a multivariable generalized linear mixed model, ICA was associated with body mass index (BMI) <20 (odds ratio [OR]: 2.04, 95% CI, 1.05-3.98; P = .0386), BMI ≥40 (2.16 [1.12-4.19]; P = .022), Model for End-Stage Liver Disease (MELD) score: (MELD 30-39: 1.75 [1.09-2.79], P = .02; MELD ≥40: 2.73 [1.53-4.85], P = .001), postreperfusion syndrome (PRS) (3.83 [2.75-5.34], P < .001), living donors (2.13 [1.16-3.89], P = .014), and reoperation (1.87 [1.13-3.11], P = .015). Overall 30-day and 1-year mortality were 4.18% and 11.0%, respectively. After ICA, 30-day and 1-year mortality were 43.9% and 52%, respectively, compared to 2.6% and 9.3% without ICA. We established a 3.7% incidence of ICA and a 1.2% incidence of intraoperative mortality in liver transplantation and confirmed previously identified risk factors for ICA including BMI, MELD score, PRS, and reoperation and identified new risk factors including living donor and length of surgery in this multicenter retrospective cohort. ICA, while rare, is associated with high intraoperative mortality, and future research must focus on therapy to reduce the incidence of ICA.

Sections du résumé

BACKGROUND
Intraoperative cardiac arrest (ICA) has a reported frequency of 1 in 10,000 anesthetics but has a much higher estimated incidence in orthotopic liver transplantation (OLT). Single-center studies of ICA in OLT are limited by small sample size that prohibits multivariable regression analysis of risks.
METHODS
Utilizing data from 7 academic medical centers, we performed a retrospective, observational study of 5296 adult liver transplant recipients (18-80 years old) between 2000 and 2017 to identify the rate of ICA, associated risk factors, and outcomes.
RESULTS
ICA occurred in 196 cases (3.7% 95% confidence interval [CI], 3.2-4.2) and mortality occurred in 62 patients (1.2%). The intraoperative mortality rate was 31.6% in patients who experienced ICA. In a multivariable generalized linear mixed model, ICA was associated with body mass index (BMI) <20 (odds ratio [OR]: 2.04, 95% CI, 1.05-3.98; P = .0386), BMI ≥40 (2.16 [1.12-4.19]; P = .022), Model for End-Stage Liver Disease (MELD) score: (MELD 30-39: 1.75 [1.09-2.79], P = .02; MELD ≥40: 2.73 [1.53-4.85], P = .001), postreperfusion syndrome (PRS) (3.83 [2.75-5.34], P < .001), living donors (2.13 [1.16-3.89], P = .014), and reoperation (1.87 [1.13-3.11], P = .015). Overall 30-day and 1-year mortality were 4.18% and 11.0%, respectively. After ICA, 30-day and 1-year mortality were 43.9% and 52%, respectively, compared to 2.6% and 9.3% without ICA.
CONCLUSIONS
We established a 3.7% incidence of ICA and a 1.2% incidence of intraoperative mortality in liver transplantation and confirmed previously identified risk factors for ICA including BMI, MELD score, PRS, and reoperation and identified new risk factors including living donor and length of surgery in this multicenter retrospective cohort. ICA, while rare, is associated with high intraoperative mortality, and future research must focus on therapy to reduce the incidence of ICA.

Identifiants

pubmed: 32167977
doi: 10.1213/ANE.0000000000004734
pii: 00000539-202101000-00021
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-139

Références

Ellis SJ, Newland MC, Simonson JA, et al. Anesthesia-related cardiac arrest. Anesthesiology. 2014;120:829–838.
Sprung J, Warner ME, Contreras MG, et al. Predictors of survival following cardiac arrest in patients undergoing noncardiac surgery: a study of 518,294 patients at a tertiary referral center. Anesthesiology. 2003;99:259–269.
Braz LG, Módolo NS, do Nascimento P Jr, et al. Perioperative cardiac arrest: a study of 53,718 anaesthetics over 9 yr from a Brazilian teaching hospital. Br J Anaesth. 2006;96:569–575.
Han F, Wang Y, Wang Y, et al. Intraoperative cardiac arrest: a 10-year study of patients undergoing tumorous surgery in a tertiary referral cancer center in China. Medicine (Baltimore). 2017;96:e6794.
Nunnally ME, O’Connor MF, Kordylewski H, Westlake B, Dutton RP. The incidence and risk factors for perioperative cardiac arrest observed in the national anesthesia clinical outcomes registry. Anesth Analg. 2015;120:364–370.
Matsusaki T, Hilmi IA, Planinsic RM, Humar A, Sakai T. Cardiac arrest during adult liver transplantation: a single institution’s experience with 1238 deceased donor transplants. Liver Transpl. 2013;19:1262–1271.
Lee SH, Gwak MS, Choi SJ, et al. Intra-operative cardiac arrests during liver transplantation - a retrospective review of the first 15 yr in Asian population. Clin Transplant. 2013;27:E126–E136.
Aufhauser DD Jr, Rose T, Levine M, et al. Cardiac arrest associated with reperfusion of the liver during transplantation: incidence and proposal for a management algorithm. Clin Transplant. 2013;27:185–192.
Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr, Pinsky MR. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care. 1993;8:154–160.
Fukazawa K, Pretto EA, Nishida S, Reyes JD, Gologorsky E. Factors associated with mortality within 24 h of liver transplantation: an updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013. J Clin Anesth. 2018;44:35–40.
Vannucci A, Burykin A, Krejci V, Peck T, Buchman TG, Kangrga IM. Postreperfusion cardiac arrest and resuscitation during orthotopic liver transplantation. Shock. 2011;37:34–38.
Quinn TD, Brovman EY, Aglio LS, Urman RD. Factors associated with an increased risk of perioperative cardiac arrest in emergent and elective craniotomy and spine surgery. Clin Neurol Neurosurg. 2017;161:6–13.
Vane MF, do Prado Nuzzi RX, Aranha GF, et al. Perioperative cardiac arrest: an evolutionary analysis of the intra-operative cardiac arrest incidence in tertiary centers in Brazil. Braz J Anesthesiol. 2016;66:176–182.
VanWagner LB, Serper M, Kang R, et al. Factors associated with major adverse cardiovascular events after liver transplantation among a national sample. Am J Transplant. 2016;16:2684–2694.
Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant. 2018;18suppl 1172–253.
Goswami S, Brady JE, Jordan DA, Li G. Intraoperative cardiac arrests in adults undergoing noncardiac surgery. Surv Anesthesiol. 2013;57:70.
Giorgakis E, Tedeschi M, Bonaccorsi-Riani E, et al. The effect of recipient body mass index and its extremes on survival and graft vascular and biliary complications after liver transplantation: a single center retrospective study. Ann Transplant. 2017;22:611–621.
Fried LP, Tangen CM, Walston J, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156.
Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014;14:1870–1879.
Haugen CE, McAdams-DeMarco M, Holscher CM, et al. Multicenter study of age, frailty, and waitlist mortality among liver transplant candidates. Ann Surg. 2019 January 18 [Epub ahead of print].
Guaraldi G, Dolci G, Zona S, et al. A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients. AIDS Res Ther. 2017;14:37.
Dolgin NH, Martins PN, Movahedi B, Lapane KL, Anderson FA, Bozorgzadeh A. Functional status predicts postoperative mortality after liver transplantation. Clin Transplant. 2016;30:1403–1410.
Shi Y, Huang B, Deng R, Ma Y. The Association of obesity with vascular complications after liver transplantation. BMC Gastroenterol. 2019;19:1–9.
Ata N, Ayloo S, Tsung A, Molinari M. Recipient obesity does not affect survival after deceased donor liver transplantation for hepatocellular carcinoma. A national retrospective cohort study in the United States. HPB (Oxford). 2019;21:67–76.
Yu JW, Gupta G, Kang L, et al. Obesity does not significantly impact outcomes following simultaneous liver kidney transplantation: review of the UNOS database - a retrospective study. Transpl Int. 2019;32:206–217.
Xu ZD, Xu HT, Yuan HB, et al. Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience. Hepatobiliary Pancreat Dis Int. 2012;11:34–39.
Paugam-Burtz C, Kavafyan J, Merckx P, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl. 2009;15:522–529.
Chung IS, Kim HY, Shin YH, et al. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Clin Transplant. 2012;26:539–543.
Bastos-Neves D, Salvalaggio PRO, Almeida MD. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction. Hepatobiliary Pancreat Dis Int. 2019;18:423–429.
Sirivatanauksorn Y, Taweerutchana V, Limsrichamrern S, et al. Recipient and perioperative risk factors associated with liver transplant graft outcomes. Transplant Proc. 2012;44:505–508.
Park JB, Kwon CH, Choi GS, et al. Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation. 2008;86:1536–1542.
Berumen J, Hemming A. Liver retransplantation: how much is too much?. Clin Liver Dis. 2017;21:435–447.
Markmann JF, Markowitz JS, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg. 1997;226:408–418.
Kim H, Lee KW, Yi NJ, et al. Outcome and technical aspects of liver retransplantation: analysis of 25-year experience in a single major center. Transplant Proc. 2015;47:727–729.
Kim SH, Kil HK, Kim HJ, Koo BN. Risk assessment of mortality following intraoperative cardiac arrest using possum and P-POSSUM in adults undergoing non-cardiac surgery. Yonsei Med J. 2015;56:1401–1407.
Sebbag I, Carmona MJ, Gonzalez MM, et al. Frequency of intraoperative cardiac arrest and medium-term survival. Sao Paulo Med J. 2013;131:309–314.
Hogen R, Dhanireddy K, Clark D, et al. Balanced blood product transfusion during liver transplantation. Clin Transplant. 2018;32:e13191.

Auteurs

Natalie K Smith (NK)

From the Department of Anesthesiology, Perioperative and Pain Medicine, The Icahn School of Medicine at Mount Sinai, New York City, New York.

Jeron Zerillo (J)

From the Department of Anesthesiology, Perioperative and Pain Medicine, The Icahn School of Medicine at Mount Sinai, New York City, New York.

Sang Jo Kim (SJ)

Department of Anesthesiology, Hospital for Special Surgery, New York City, New York.

Guy E Efune (GE)

Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.

Cynthia Wang (C)

Department of Anesthesiology, Greater Los Angeles VA Healthcare System, Los Angeles, California.

Sher-Lu Pai (SL)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida.

Ryan Chadha (R)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida.

Todd M Kor (TM)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.

David R Wetzel (DR)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.

Michael A Hall (MA)

Department of Anesthesiology, Christiana Care Health System, Newark, Delaware.

Kristen K Burton (KK)

Department of Anesthesiology and Critical Care, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania.

Kyota Fukazawa (K)

Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington.

Bryan Hill (B)

Department of Anesthesiology, The Ohio State University, Columbus, Ohio.

Mia-Ashley Spad (MA)

New York Medical College, Valhalla, New York.

David B Wax (DB)

From the Department of Anesthesiology, Perioperative and Pain Medicine, The Icahn School of Medicine at Mount Sinai, New York City, New York.

Hung-Mo Lin (HM)

Department of Population Health Science and Policy, The Icahn School of Medicine at Mount Sinai, New York City, New York.

Xiaoyu Liu (X)

Department of Anesthesiology, University of Kansas Medical Center, Kansas City, Kansas.

Jaffer Odeh (J)

Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.

Laurence Torsher (L)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.

James D Kindscher (JD)

Department of Anesthesiology, University of Kansas Medical Center, Kansas City, Kansas.

M Susan Mandell (MS)

Department of Anesthesiology, University of Colorado Hospital, Aurora, Colorado.
The Center for Perioperative & Pain Quality, Safety and Outcomes-PPQiSO, University of Washington Medical Center, Seattle, Washington.

Tetsuro Sakai (T)

Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Samuel DeMaria (S)

From the Department of Anesthesiology, Perioperative and Pain Medicine, The Icahn School of Medicine at Mount Sinai, New York City, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH